ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
0.005
0.00
(0.00%)
Closed January 07 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.005
Bid
0.005
Ask
0.005
Volume
-
0.00 Day's Range 0.00
0.005 52 Week Range 0.01
Market Cap
Previous Close
0.005
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
77,187,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
989k
Net Profit
-6.07M

About Avivagen Inc

Sector
Coml Physical, Biologcl Resh
Industry
Pharmaceutical Preparations
Headquarters
Ottawa, Ontario, Can
Founded
2012
Avivagen Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker VIV. The last closing price for Avivagen was $0.01. Over the last year, Avivagen shares have traded in a share price range of $ 0.005 to $ 0.01.

Avivagen currently has 77,187,000 shares outstanding. The market capitalization of Avivagen is $385,935 .

VIV Latest News

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - VIV

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - VIV Canada NewsWire VANCOUVER, BC, le 6 mars 2024 VANCOUVER, BC, le 6 mars 2024 /CNW/...

Canadian Investment Regulatory Organization Trading Halt - VIV

Canadian Investment Regulatory Organization Trading Halt - VIV Canada NewsWire VANCOUVER, BC, March 6, 2024 VANCOUVER, BC, March 6, 2024 /CNW/ - The following issues have been halted by...

Avivagen Announces Appointment of James Nickerson as President

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that...

Avivagen Continues Market Growth with New Customer Win in Western Mexico

Order signifies important growth in key production territories in Mexico Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing...

Avivagen Announces Recurring Order for OxC-betaTM Livestock

Largest purchase amount and longest duration purchase to-date Four tonne per month order secured Order follows five successful OxC-betaTM Livestock commercial trials conducted with various...

Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per share to satisfy the maintenance fee...

Avivagen anuncia la inminente publicación de una investigación que destaca los beneficios de OxC-betaTM Livestock para las ...

Dicho estudio se publicará próximamente en la prestigiosa revista Poultry Science. Poultry Science es una revista internacionalmente reconocida, considerada como la fuente autorizada de una...

Avivagen Announces Upcoming Research Publication Highlighting The Benefits Of OxC-betaTM Livestock for Broiler Poultry

Study to be published soon in leading peer-reviewed journal Poultry Science. Poultry Science is an internationally renowned journal, known as the authoritative source for a broad range of...

Avivagen confía en Meyenberg International Group para dirigir sus actividades de expansión en América Central y del Sur

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) («Avivagen»), empresa de ciencias biológicas dedicada a desarrollar y comercializar productos para el ganado, los animales de compañía y aplicaciones humanas...

Avivagen Selects Meyenberg International Group to Spearhead Expansion Efforts in Central and South America

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0050.0050.00500CS
4000.0050.0050.00500CS
12000.0050.0050.00500CS
26000.0050.0050.00500CS
52-0.005-500.010.010.00568010.005CS
156-0.28-98.24561403510.2850.3050.005445950.0822233CS
260-0.565-99.12280701750.570.780.005532550.31082805CS

VIV - Frequently Asked Questions (FAQ)

What is the current Avivagen share price?
The current share price of Avivagen is $ 0.005
How many Avivagen shares are in issue?
Avivagen has 77,187,000 shares in issue
What is the market cap of Avivagen?
The market capitalisation of Avivagen is CAD 385.94k
What is the 1 year trading range for Avivagen share price?
Avivagen has traded in the range of $ 0.005 to $ 0.01 during the past year
What is the reporting currency for Avivagen?
Avivagen reports financial results in CAD
What is the latest annual turnover for Avivagen?
The latest annual turnover of Avivagen is CAD 989k
What is the latest annual profit for Avivagen?
The latest annual profit of Avivagen is CAD -6.07M
What is the registered address of Avivagen?
The registered address for Avivagen is 100 SUSSEX DRIVE, OTTAWA, ONTARIO, K1A 0R6
What is the Avivagen website address?
The website address for Avivagen is www.avivagen.com
Which industry sector does Avivagen operate in?
Avivagen operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FINV.PFaction Investment Group Corp
$ 0.05
(233.33%)
17k
ADG.HArcus Development Group Inc
$ 0.015
(200.00%)
10k
AZC.PA2ZCryptocap Inc
$ 0.095
(171.43%)
1.01k
CBAChampion Bear Resources Ltd
$ 0.035
(133.33%)
9k
XBOTRealbotix Corp
$ 0.56
(124.00%)
7.15M
MSPMinaean SP Construction Corp
$ 0.005
(-66.67%)
7k
MUST.HMust Capital Inc
$ 0.025
(-58.33%)
215k
CART.HCarcetti Capital Corp
$ 0.13
(-51.85%)
4.5k
NICKNickelex Resource Corporation
$ 0.005
(-50.00%)
300k
IDIdentillect Technologies Corp
$ 0.005
(-50.00%)
425k
GPUSAlset AI Ventures Inc
$ 0.21
(31.25%)
10.69M
MATEBlockmate Ventures Inc
$ 0.375
(-8.54%)
7.24M
XBOTRealbotix Corp
$ 0.56
(124.00%)
7.15M
QNCQuantum Emotion Corp
$ 1.76
(21.38%)
6.09M
AECAnfield Energy Inc
$ 0.095
(5.56%)
3.84M

Discussion

View Full Feed
FNM500K FNM500K 7 minutes ago
https://www.nationalmortgagenews.com/news/fannie-freddie-release-likely-its-just-a-matter-of-when
FNMA
JMoneyHoops JMoneyHoops 8 minutes ago
Pink Limited: https://x.com/jmoney_hoops/status/1876527065773776928?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
Tesla Trillionaire Tesla Trillionaire 13 minutes ago
Tesla could see 400% increase when Trump takes office. 
TSLA
kBletsgo30 kBletsgo30 13 minutes ago
I'm in the hiring process at Lilly in Indianapolis so I'll have a chat and let you know more tomorrow ha. 
Lol would be cool if we were bought out by Lilly while I work there 
RSPI
nowwhat2 nowwhat2 25 minutes ago
XRP simply needs to get above 2.47 and

https://investorshub.advfn.com/uimage/uploads/2025/1/7/qngfvtot_!_3m_730am_btc_bo_banana_100k.jpg




12 HOURS LATER.....WOW
https://investorshub.advfn.com/uimage/uploads/2025/1/7/hhvogtot_!_6_3m_10pm_wow
Sheepdog Sheepdog 30 minutes ago
I told you....it is in the PR from 2-1/2 weeks ago.
GTLL
Juststoppingby Juststoppingby 33 minutes ago
We have been focusing only on Core Optics' financials.

Core Optics acquired Core Optics Co. Ltd.'s business, including tangible assets and the transfer of intellectual property rights. Quote from Core Optics website:
“Core Optics LLC proudly announces the acquisition of Core Op
CRTG
jondoeuk jondoeuk 36 minutes ago
It is a pilot trial, but mPDAC is the largest category at diagnosis. Depending on the data (and if a pivotal trial ends up being successful), TTFs could eventually be used across all diagnosis categories.
NVCR
nowwhat2 nowwhat2 37 minutes ago
XRP simply needs to get above 2.47 and

https://investorshub.advfn.com/uimage/uploads/2025/1/7/qngfvtot_!_3m_730am_btc_bo_banana_100k.jpg




12 HOURS LATER.....WOW
https://investorshub.advfn.com/uimage/uploads/2025/1/7/hhvogtot_!_6_3m_10pm_wow
XRPUSD
KILLAZILLA KILLAZILLA 38 minutes ago
BULLSHIT!!!!

THE LYING GRIFTERS DIDN'T "FUND" ANYTHING UNTIL they GOT THE LOAN!!!
XERI
KILLAZILLA KILLAZILLA 40 minutes ago
NOTICE THIS POS SCAM HAS NO VOLUME BECAUSE you CAN'T BUY.

CAN'T DILUTE WITH NO BUYING ALLOWED!!!

SILLY PUMPER!!!!
INQD
zakattack zakattack 42 minutes ago
https://wyobiz.wyo.gov/Business/FilingDetails.aspx?eFNum=254072092126007022126185144195011214106207248131
GNCP
STILL TOWING STILL TOWING 45 minutes ago
He's always had a huge set, i guess the cartels thought they were too big?
MRGE
Zorax Zorax 47 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/7/gjdkfTrmpBrainF1-25_-_Copy.JPG
sage4 sage4 49 minutes ago
The title of an article by him is intersting:
(click the collection of his articles on AVXL at the bottom in the link and scroll down)

The Ticket to Approval of Balracamesine is The OLE Data
Jul 29, 2024
AVXL
CrimsonNightRider CrimsonNightRider 50 minutes ago
Into IR pockets…

https://investorshub.advfn.com/uimage/uploads/2024/12/22/qesbw36A86B0A-AC9A-4CF1-BB9C-B2FC097A12C4.gif
ILLR
DTGoody DTGoody 50 minutes ago
The most powerful church in America:

https://www.facebook.com/share/r/15hqDwhNGK/
CrimsonNightRider CrimsonNightRider 52 minutes ago
You gotta be shitting me…pump it like you mean it.

https://investorshub.advfn.com/uimage/uploads/2024/12/22/bhtyfD8BC8B90-FBAF-435A-BE93-3ABB8193D1D3.gif
ILLR
Juststoppingby Juststoppingby 53 minutes ago
From 8-K Nov 14, 2024
Schedule I
Risk Factors
To maintain our “current” reporting status with the SEC, we are required to file our Form 10-Q for the quarter ended September 30, 2024, within the SEC’s prescribed timeline. However, due to complexities arising from the recent share
CRTG

Your Recent History

Delayed Upgrade Clock